Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment
Clinical trial NCT01087502 · COMPLETED
Trial details
- NCT number
- NCT01087502
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-05-01
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.